Condition guide · 8 min read

Ménière's disease — supplement adjuncts and what to skip

Updated 2026-05-20 · Reviewed by SupplementScore editors · No sponsorships

Ménière's disease is an inner-ear disorder marked by recurrent vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. The mainstay interventions are dietary (low sodium, alcohol and caffeine moderation, even hydration), pharmacological (betahistine where licensed, diuretics in some protocols), and intratympanic or surgical procedures for refractory cases. The supplement layer is small but credible — and the trigger list usually matters more than any pill.

This is adjunctive, not curative. Acute vertigo with new neurologic symptoms, sudden hearing loss, or first-episode imbalance needs urgent ENT or neurology assessment to rule out stroke, vestibular schwannoma, and other mimics. No supplement substitutes for that workup.

The behavioural foundation — read this first

The most consistent observational and small-trial signal in Ménière's is lifestyle, not pharmacology or supplements. A low-sodium pattern (typically <2 g/day) combined with consistent fluid intake, alcohol moderation, caffeine moderation, smoking cessation, and migraine-style trigger avoidance (sleep regularity, stress management) reduces attack frequency in much of the cohort. Any supplement protocol assumes these are in place.

Supplements with credible adjunctive evidence

Tier 2 · Often low in Ménière's cohorts

Vitamin D3

1000–2000 IU/day, titrated to 25-OH-D 30–50 ng/mL

Vitamin D deficiency is more common in patients with Ménière's than in matched controls in several cross-sectional series. Small intervention studies suggest deficiency correction may modestly reduce attack frequency, though the mechanism is unclear (possibly via inner-ear ion homeostasis or general immune modulation). Test 25-OH-D and supplement to the normal range. Routine high-dose empirical dosing is not appropriate.

Tier 2 · Vestibular migraine overlap

Magnesium glycinate

300–400 mg elemental magnesium daily

A meaningful subset of patients with episodic vertigo and Ménière-like attacks have vestibular migraine rather than (or in addition to) true Ménière's. Magnesium at 600 mg/day has Grade B AAN evidence for migraine prevention; the lower 300–400 mg dose is well tolerated and is the most common starting point. Worth a 6–8 week trial if migraine history is present or attacks are migraine-like.

Tier 2 · Inner-ear and vestibular indications

Vitamin B12

500–1000 mcg methylcobalamin or hydroxocobalamin daily

B12 deficiency causes a wide range of neurologic symptoms including tinnitus and balance disturbance. Patients with low or low-normal B12 may experience some symptom reduction with repletion. Test serum B12 (and methylmalonic acid if borderline) before supplementing. This is repletion logic, not a Ménière-specific treatment.

Tier 2 · Acute symptom relief

Ginger (Zingiber officinale)

500–1000 mg standardised extract, as needed for acute nausea

Ginger has good evidence for nausea — including motion sickness and chemotherapy-induced nausea — and is a reasonable acute symptom-management tool during vertigo episodes. It does not reduce attack frequency or address the underlying inner-ear pathology, but it can make episodes more tolerable. Pair with the prescribed vestibular suppressant (e.g. meclizine) if your physician has provided one.

Tier 3 · Limited evidence, common in protocols

Coenzyme Q10

100–200 mg ubiquinol or ubiquinone daily

Used in some migraine-overlap protocols and in vestibular schwannoma-adjacent care. The direct Ménière trial evidence is thin. Consider if migraine history is strong. Not a primary intervention.

What to skip

Practical priority list. Behavioural foundations (sodium, alcohol, caffeine, sleep, migraine triggers) → ENT-directed pharmacotherapy (betahistine where licensed, diuretic if recommended) → vitamin D repletion if low → magnesium 300–400 mg/day if migraine overlap → B12 repletion if low → ginger acutely for nausea. If attacks are frequent and disabling despite these measures, escalate to intratympanic therapy or surgical consultation.

Sources

Read more: